Australia markets close in 35 minutes

CalciMedica, Inc. (CALC)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
5.180.00 (0.00%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 55.68M
Enterprise value 16.76M
Trailing P/E 0.33
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)3.23
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 320.97%
S&P500 52-week change 324.96%
52-week high 38.38
52-week low 31.75
50-day moving average 35.23
200-day moving average 34.05

Share statistics

Avg vol (3-month) 317.94k
Avg vol (10-day) 314.1k
Shares outstanding 510.75M
Implied shares outstanding 610.75M
Float 84.56M
% held by insiders 114.67%
% held by institutions 159.64%
Shares short (15 May 2024) 430.2k
Short ratio (15 May 2024) 42.03
Short % of float (15 May 2024) 40.52%
Short % of shares outstanding (15 May 2024) 40.28%
Shares short (prior month 15 Apr 2024) 433.61k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-43.49%
Return on equity (ttm)-76.09%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -21.44M
Net income avi to common (ttm)-14.94M
Diluted EPS (ttm)15.78
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)25.71M
Total cash per share (mrq)2.39
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)6.21
Book value per share (mrq)1.61

Cash flow statement

Operating cash flow (ttm)-25.09M
Levered free cash flow (ttm)-10.44M